Roivant Sciences Statistics Share Statistics Roivant Sciences has 682.88M
shares outstanding. The number of shares has increased by -8.07%
in one year.
Shares Outstanding 682.88M Shares Change (YoY) -8.07% Shares Change (QoQ) -4.73% Owned by Institutions (%) 76.56% Shares Floating 417.7M Failed to Deliver (FTD) Shares 10,276 FTD / Avg. Volume 0.15%
Short Selling Information The latest short interest is 36.21M, so 5.3% of the outstanding
shares have been sold short.
Short Interest 36.21M Short % of Shares Out 5.3% Short % of Float 7.11% Short Ratio (days to cover) 3.87
Valuation Ratios The PE ratio is -42.56 and the forward
PE ratio is -11.78.
Roivant Sciences's PEG ratio is
0.41.
PE Ratio -42.56 Forward PE -11.78 PS Ratio 251.93 Forward PS 513.7 PB Ratio 1.56 P/FCF Ratio -8.67 PEG Ratio 0.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Roivant Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 33.47,
with a Debt / Equity ratio of 0.02.
Current Ratio 33.47 Quick Ratio 33.47 Debt / Equity 0.02 Debt / EBITDA -0.15 Debt / FCF -0.12 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $32K Profits Per Employee $-189.41K Employee Count 908 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax 48.17M Effective Tax Rate -7.07%
Stock Price Statistics The stock price has increased by 32.14% in the
last 52 weeks. The beta is 1.15, so Roivant Sciences's
price volatility has been higher than the market average.
Beta 1.15 52-Week Price Change 32.14% 50-Day Moving Average 12.54 200-Day Moving Average 11.37 Relative Strength Index (RSI) 73.8 Average Volume (20 Days) 6,726,420
Income Statement In the last 12 months, Roivant Sciences had revenue of 29.05M
and earned -171.98M
in profits. Earnings per share was -0.24.
Revenue 29.05M Gross Profit 28.14M Operating Income -1B Net Income -171.98M EBITDA -674.26M EBIT -1.11B Earnings Per Share (EPS) -0.24
Full Income Statement Balance Sheet The company has 2.72B in cash and 100.17M in
debt, giving a net cash position of 2.62B.
Cash & Cash Equivalents 2.72B Total Debt 100.17M Net Cash 2.62B Retained Earnings 116.06M Total Assets 5.03B Working Capital 4.5B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -839.45M
and capital expenditures -4.6M, giving a free cash flow of -844.05M.
Operating Cash Flow -839.45M Capital Expenditures -4.6M Free Cash Flow -844.05M FCF Per Share -1.16
Full Cash Flow Statement Margins Gross margin is 96.86%, with operating and profit margins of -3453.32% and -591.96%.
Gross Margin 96.86% Operating Margin -3453.32% Pretax Margin -2346.02% Profit Margin -591.96% EBITDA Margin -2320.79% EBIT Margin -3453.32% FCF Margin -2905.21%
